Clinical Trial Update: Neoadjuvant Therapy for Locally Advanced Low Rectal Cancer (SMARTi-RC01) [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant therapy trial for locally advanced low rectal cancer (SMARTi-RC01) is ongoing. Status: not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Colorectal Cancer (Diagnosis) | Phase 2 | Status: NOT_YET_RECRUITING